4
Changes in Ownership
10x Genomics, Inc. Filed Acc 0001209191-21-020877
Chief Executive Officer sold 15,000 shares at an average $157.04 ($2,355,569)
- Chief Executive Officer acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Saxonov Serge · Chief Executive Officer
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-12 | Exercise or conversion : show line 1 in the form | +5,209 | $5.04 | $26,253 | 885,677 | D |
| 2021-03-12 | Exercise or conversion : show line 2 in the form | +9,791 | $11.48 | $112,401 | 895,468 | D |
| 2021-03-12 | Sale : show line 3 in the form | −1,500 | $154.37 | $231,551 | 893,968 | D |
| 2021-03-12 | Sale : show line 4 in the form | −2,904 | $155.35 | $451,147 | 891,064 | D |
| 2021-03-12 | Sale : show line 5 in the form | −3,105 | $156.35 | $485,463 | 887,959 | D |
| 2021-03-12 | Sale : show line 6 in the form | −2,384 | $157.42 | $375,285 | 885,575 | D |
| 2021-03-12 | Sale : show line 7 in the form | −1,933 | $158.49 | $306,355 | 883,642 | D |
| 2021-03-12 | Sale : show line 8 in the form | −3,174 | $159.35 | $505,768 | 880,468 | D |
| Open-market sales · 15,000 sh · avg $157.04 · $2,355,569 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-03-12 | Exercise or conversion : show line 9 in the form Stock Option (right to buy) | −5,209 | $5.04 | 2028-11-02 | 5,209 | 100,198 | D |
| 2021-03-12 | Exercise or conversion : show line 10 in the form Stock Option (right to buy) | −9,791 | $11.48 | 2029-05-10 | 9,791 | 116,880 | D |
Loading xslF345X03/doc4.xml…